Finance

Beta
Lists
CLDX:NASDAQ
Celldex Therapeutics Inc
$28.62
-4.38%
(-1.31) 1D
Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLDX...
Open
$29.83
High
$30.05
Low
$28.46
Mkt. cap
2.25B
Avg. vol.
722.01K
Volume
0.00
52-wk high
$35.79
52-wk low
$19.52
EPS
-$4.27
Beta
0.95
Shares outstanding
78.49M
No. of employees
198
Open
$29.83
High
$30.05
Low
$28.46
Mkt. cap
2.25B
Avg. vol.
722.01K
Volume
0.00
52-wk high
$35.79
52-wk low
$19.52
EPS
-$4.27
Beta
0.95
Shares outstanding
78.49M
No. of employees
198
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to CLDX in the past 3 months
Strong Buy
Buy
7
Hold
1
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CLDX in the last 3 months.
Highest
Current $28.62
$67.00 (+134.10%)
Average
$50.71 (+77.18%)
Lowest
$38.00 (+32.77%)
News stories
From sources across the web
About Celldex Therapeutics Inc
CEO-
Employees198
Founded1983
HeadquartersHampton, New Jersey, United States
SectorBiotechnology
Websitecelldex.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
730.00K
-
121.00K
15.00K
Cost of goods sold
54.20M
62.93M
75.33M
73.00M
Cost of revenue
54.20M
62.93M
75.33M
73.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.39M
10.69M
11.94M
11.45M
Operating expense
10.39M
10.69M
11.94M
11.45M
Total operating expenses
64.59M
73.62M
87.27M
84.45M
Operating income
-63.86M
-73.62M
-87.15M
-84.44M
Other non operating income
-
-
-
-
EBT including unusual items
-56.60M
-67.04M
-81.32M
-78.68M
EBT excluding unusual items
-56.60M
-67.04M
-81.32M
-78.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-56.60M
-67.04M
-81.32M
-78.68M
Net profit margin
-7,753.42%
-
-67,204.13%
-524,566.67%
Earnings per share
-0.85
-1.01
-1.22
-1.18
Interest and investment income
7.26M
6.57M
5.84M
5.75M
Interest expense
-
-
-
-
Net interest expenses
7.26M
6.57M
5.84M
5.75M
Depreciation and amortization charges
-
-
-
-
EBITDA
-62.98M
-72.79M
-86.34M
-83.58M
Gain or loss from assets sale
2.00K
6.00K
-
3.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer